Zimmer to distribute Baxter's Infusor:
This article was originally published in Clinica
Executive Summary
Zimmer has gained distribution rights to Baxter Healthcare's Infusor device, allowing the former to market the product as part of a pain management kit for orthopaedic and non-oncology surgical procedures in the US. The portable and disposable Infusor employs elastomeric technology to provide a slow, continuous administration of medication following a surgical procedure. Sales of the system are expected to commence in the first quarter of 2005.
You may also be interested in...
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.